These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 825588)
21. Gentamicin resistance in gram-negative bacilli: occurrence of modifying enzymes and their influence on susceptibility testing. Dornbusch K; Hallander HO Scand J Infect Dis; 1980; 12(4):295-302. PubMed ID: 6779372 [TBL] [Abstract][Full Text] [Related]
22. In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Dhawan V; Marso E; Martin WJ; Young LS Antimicrob Agents Chemother; 1977 Jan; 11(1):64-73. PubMed ID: 836015 [TBL] [Abstract][Full Text] [Related]
23. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics. Kabins SA; Nathan C; Cohen S Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021 [TBL] [Abstract][Full Text] [Related]
24. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics. Meyer RD; Draus LL; Pasieczinik KA Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036 [TBL] [Abstract][Full Text] [Related]
25. A laboratory assessment of the activities of four aminoglycosides. Schrire L; Robinson RG; Koornhof HJ S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946 [TBL] [Abstract][Full Text] [Related]
27. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates. Stewart D; Bodey GP J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415 [TBL] [Abstract][Full Text] [Related]
28. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin. Brewer NS Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988 [TBL] [Abstract][Full Text] [Related]
29. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy. Bovelacci A; Montini G; Ramacciotti PG Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413 [TBL] [Abstract][Full Text] [Related]
30. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods. Drasar FA; Farrell W; Maskell J; Williams JD Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196 [TBL] [Abstract][Full Text] [Related]
31. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin. Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006 [TBL] [Abstract][Full Text] [Related]
32. Sensitivity of gram-negative bacteria to six aminoglycoside antibiotics. Eyckmans L; Beert J Infection; 1977; 5(1):9-12. PubMed ID: 404254 [TBL] [Abstract][Full Text] [Related]
33. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. Washington JA; Snyder RJ; Kohner PC; Wiltse CG; Ilstrup DM; McCall JT J Infect Dis; 1978 Feb; 137(2):103-11. PubMed ID: 415096 [TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus. Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899 [TBL] [Abstract][Full Text] [Related]
38. The comparative in-vitro activity of pefloxacin. King A; Phillips I J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213 [TBL] [Abstract][Full Text] [Related]
39. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy. Saavedra S; Vera D; Ramírez-Ronda CH Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877 [TBL] [Abstract][Full Text] [Related]
40. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods]. Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]